Clinical Trials Directory

Trials / Terminated

TerminatedNCT01141621

The Dallas Hereditary Spherocytosis Cohort Study

Status
Terminated
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to 1. better characterize the short term and long term natural history of hereditary spherocytosis (HS) including diagnosis, complications, and indications for and response to splenectomy 2. evaluate and describe the health-related quality of life in children with HS.

Detailed description

Patients with a new or established diagnosis of HS seen at Children's Medical Center will be asked to enroll in the study. Previous and current medical records will be reviewed to systematically catalogue their history of HS, including diagnosis, complications, hospitalizations, medications and laboratory data. Health-related quality of life questionnaires will be given to the patients and their parents at enrollment and periodically during the follow-up. Those who agree will have up to three small samples of blood collected and frozen for future laboratory studies of complications associated with HS and/or splenectomy. We anticipate enrolling approximately 200 children and young adults with HS in this study and following them until adulthood (age 18-21 years).

Conditions

Timeline

Start date
2010-05-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2010-06-10
Last updated
2013-05-14

Source: ClinicalTrials.gov record NCT01141621. Inclusion in this directory is not an endorsement.

The Dallas Hereditary Spherocytosis Cohort Study (NCT01141621) · Clinical Trials Directory